outcomes research

Research in Review

Autologous Stem Cell Transplantation Improves Outcomes for Patients With MCL

04/11/2017

JCP Editors

Patients with mantle cell lymphoma (MCL) benefit from prolonged event-free survival (EFS) and overall survival (OS) when treated with autologous stem cell transplantation (ASCT) and total body irradiation, according...

...

04/11/2017

Journal of Clinical Pathways

Research in Review

Neurofeedback Reduces Nerve Damage From Chemotherapy in Cancer Survivors

04/11/2017

JCP Editors

Chemotherapy-induced peripheral neuropathy (CIPN) may be significantly reduced by electroencephalogram (EEG) neurofeedback training, according to research published in Cancer (published online March 3, 2017;...

...

04/11/2017

Journal of Clinical Pathways

Research in Review

New Drug Improves PFS for Patients With ALK-Positive NSCLC

04/10/2017

JCP Editors

Patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) live significantly longer without disease progression when treated with a new drug compared with those treated with...

...

04/10/2017

Journal of Clinical Pathways

Research in Review

Immune Systems Impact Immunotherapy Effectiveness in Head and Neck Cancer

04/05/2017

JCP Editors

Specific immune cells surrounding tumors may play a crucial role in how patients with head and neck cancer respond to nivolumab immunotherapy, according to research presented at the American Association of Cancer...

...

04/05/2017

Journal of Clinical Pathways

Research in Review

Combined Treatment Approach Improves Survival for Patients With Glioblastoma

04/03/2017

JCP Editors

A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial. ----- Related...

A...

04/03/2017

Journal of Clinical Pathways

Research in Review

Hypersensitivity Reactions Present Clinical, Economic Burden for Patients With NSCLC

03/24/2017

JCP Editors

Patients with non-small cell lung cancer (NSCLC) who develop hypersensitivity reactions to first-line chemotherapy are faced with increasing clinical burden and rising costs, according to research presented at the...

...

03/24/2017

Journal of Clinical Pathways

Research in Review

Hormonal Maintenance Therapy Improves PFS for Patients With Ovarian Cancer

03/21/2017

JCP Editors

Women with stage II-IV low-grade serous carcinoma of the ovary or peritoneum who received hormonal maintenance therapy after primary treatment had longer progression-free survival (PFS) compared with women who...

Women...

03/21/2017

Journal of Clinical Pathways

Research in Review

Shorter Radiotherapy Regimen Effective in Treating Localized Prostate Cancer

03/20/2017

JCP Editors

A 4-week precision radiotherapy regimen is as effective and safe as the standard 8-week regimen for treating localized prostate cancer, according to research published in the Journal of Clinical Oncology (published...

A...

03/20/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Efficacy of B-Cell Lymphoma Treatment

03/20/2017

JCP Editors

Combining two treatment strategies for the treatment of B-cell lymphoma may be more effective than either strategy alone, according to a study published in Cell Reports (February 28,...

...

03/20/2017

Journal of Clinical Pathways

Research in Review

Multikinase Inhibitors Ineffective in Treating RET-Rearranged NSCLC

03/17/2017

JCP Editors

Overall response rate (ORR) is low for patients with non-small cell lung cancer (NSCLC) with RET rearrangements after targeted therapy, according to research published in the Journal of Clinical Oncology (March 13,...

...

03/17/2017

Journal of Clinical Pathways